News & Articles
Selected Filters:
Why serology tests are shaping the future of vaccine development
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response
12 expert webinars and virtual events coming up this week
Explore topics from Alzheimer's disease and mRNA vaccine production to SARS-CoV-2 detection in wastewater and nanoplastic characterization
Europe’s first ‘game-changing’ portable MRI machine arrives at King’s Health Partners
This cutting-edge technology has the potential to vastly improve care, offering accessible and affordable brain imaging that can take place at the patient’s bedside
‘The basic foundation for science is transparent and open communication’
Dr. Vikramsingh Gujar, from Northwestern University, discusses his research on inflammatory disorders and why effective knowledge share is vital for scientific advancement
10x Genomics unlocks whole transcriptome analysis in FFPE tissues with new Visium assay, now shipping
The assay is fueling discovery in preserved tissue samples to advance clinical translational research
Abbott receives European and Canadian approval for Amplatzer
The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation
Ori Biotech selected to join cell and gene therapy process analytical technology consortium project
Consortium formed to lower costs of cell and gene therapies through process development and manufacturing collaborations
Protein identified as new therapeutic anti-viral target for COVID-19
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
Blood clot-busting nanocapsules could reduce existing treatment’s side effects
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot-dissolving drug, which include bleeding on the brain
Genetic Analysis AS awarded NOK 16 million (USD 1.9 million) to develop new microbiome marker to aid treatment of inflammatory bowel disease
It is hoped the project will lead to improved quality of life for patients
NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost
OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients
ERS Genomics and genOway enter CRISPR/Cas9 agreement
Large-scale lung cancer clinical study demonstrates accuracy and sensitivity of Fluxion’s ERASE-Seq liquid biopsy
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR
Watch highlights from the Virtual Cancer and Immunology Research Summit 2021
Top talks presenting the latest technologies, research and applications are now available on demand
COVID-19 Vaccine AstraZeneca effective against Delta (‘Indian’) variant
Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant
BioDot accelerates customer innovation through acquisition by ATS Automation
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth
SARS-CoV-2 variants: Are Ct values an unused piece of the profiling puzzle?
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
Syndromic testing: Achieving better clinical outcomes for gastrointestinal pediatric patients
Dr. Samuel Dominguez shares the importance of robust testing methods and diagnostic stewardship
Don't miss out on these 6 expert webinars
Explore topics from NGS and disinfectants in the food and beverage industry to high-resolution ion mobility mass spectrometry, and CAR-T cell sensitivity and persistence